Andrea F. Wainer - Aug 8, 2023 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Signature
/s/ Andrea F. Wainer by Jessica H. Paik, Attorney-in-Fact
Stock symbol
ABT
Transactions as of
Aug 8, 2023
Transactions value $
-$900,297
Form type
4
Date filed
8/10/2023, 06:31 PM
Previous filing
May 3, 2023
Next filing
Dec 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Options Exercise $192K +5K +7.1% $38.40 75.4K Aug 8, 2023 Direct
transaction ABT Common shares without par value Sale -$498K -4.74K -6.29% $105.00 70.7K Aug 8, 2023 Direct
transaction ABT Common shares without par value Sale -$25.7K -244 -0.35% $105.43 70.4K Aug 8, 2023 Direct
transaction ABT Common shares without par value Sale -$1.61K -15 -0.02% $107.42 70.4K Aug 8, 2023 Direct
transaction ABT Common shares without par value Sale -$537K -5.11K -7.26% $105.00 65.3K Aug 8, 2023 Direct
transaction ABT Common shares without par value Sale -$28.7K -272 -0.42% $105.43 65K Aug 8, 2023 Direct
transaction ABT Common shares without par value Sale -$1.72K -16 -0.02% $107.42 65K Aug 8, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Option (right to buy) Options Exercise $0 -5K -100% $0.00* 0 Aug 8, 2023 Common Shares 5K $38.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.